Inflection Point Acq VI

This filing establishes the definitive terms for the de-SPAC transaction, giving investors a clear framework for redemption deadlines, trust value, minimum cash condition, and deal timeline. The $90 million minimum cash condition and the link between seller consideration and the redemption price directly affect shareholder redemption decisions and the ultimate capital available to the combined company. The PIPE commitments ($300 million total) provide a significant capital infusion. The agreement also outlines governance (7-member board, SPAC appoints 1 director) and lock-up periods (6 months for sponsor and certain insiders).

This is the most substantive statement from Quantum Space's CEO since the deal announcement. It provides a national-security rationale for the business, gives the clearest product description yet (space tanking, sustained maneuver), and ties the deal timeline to a rapidly growing Space Force budget. It also locks in a Tulsa manufacturing footprint, which is a concrete operational claim. The risk factors add granularity: Ranger has not yet been built or sold, and there are dangers from explosive materials. For a high-trust-value SPAC ($10.07) with a 2028 deadline, the lack of any deal-terms change means no immediate trigger for redemption, but the narrative is now richer for investors evaluating whether to hold or redeem.

Management supplied explicit financial and operational parameters that materially alter redemption thresholds and growth expectations. Bridenstine projects revenue scaling from $24 million in 2026 to $51 million in 2027 (Payload cites $61 million), stating the "vast preponderance" derives from milestone payments on six existing government contracts. The Space News excerpt separately records projected cash burns of $69.4 million in 2026 and $97.6 million in 2027. Blitzer anchors the commercial thesis to the U.S. Space Force’s Andromeda program, citing an IDIQ ceiling of $6.2 billion. Operational timelines include a mid-2027 pathfinder launch, expanded manufacturing across three U.S. facilities, and a production run-rate of one satellite per quarter by the end of 2028, all per Bridenstine. On sponsor conduct, Bridenstine estimates a ~7% post-transaction stake and notes Inflection Point shares are "not necessarily locked in by any type of rule or agreement," signaling potential post-close liquidity and alignment risks. Trust redemption exposure remains binary against the stated valuations, while capital deployment priorities center on accelerating Ranger production and supply-chain verticalization.

The filing provides material product-stage disclosure absent from prior structural filings. Communications attributed to Quantum Space’s official social channels and named individuals Jim Bridenstine, Kam Ghaffarian, and Kerry Wisnosky on June 8, 2026, characterize the flagship 'Ranger' satellite vehicle as actively under development but explicitly not yet manufactured, operated, or sold. The documents project a refuelable and modular architecture and an intended operational life of up to 15 years, while flagging that operations will require handling potentially explosive and ignitable energetic materials and dangerous chemicals. Risk disclosures managed by the issuer note zero current revenue, no confirmed customer contracts in production, and material execution dependencies including satellite launch success rates, prime contractor counterparty reliability, government procurement funding volatility, protest vulnerability, and continued ability to meet stock exchange listing standards. Because the combination rests on unproven hardware development rather than deployed systems or recurring revenue, shareholders weighing redemption before the March 30, 2028 deadline face asymmetric technology and regulatory risk that supersedes standard cash-trust arithmetic.

Quantum Space management projects 2026 revenues of $23,646 and 2027 revenues of $60,633, paired with forecasted operating expenses of $45,965 in 2026 and $46,728 in 2027, yielding projected total cash burns of $(69,411) and $(97,591) (all figures in USD thousands per the projection header). The company asserts a $100 billion annual industry total addressable market and reports an unweighted opportunity pipeline of approximately $5.2 billion, including a $16 million Department of Defense contract, non-binding proposals valued at $36 million with the Department of War and $30 million with DARPA, a $4 million Air Force Research Laboratory agreement, and competitive access under a $6.2 billion maximum ceiling on the Space Force Andromeda IDIQ vehicle. Executive leadership comprises CEO Jim Bridenstine and Executive Chairman Dr. Kam Ghaffarian, who previously co-founded Intuitive Machines, Axiom Space, and X-Energy. The firm's flagship Ranger platform claims more than 4,000 kilograms of storable fuel capacity and a 15-year operational lifespan, though management notes the hardware has not been manufactured, operated, or sold. Pro forma equity distribution allocates 50.2 percent to Quantum rollover shareholders, 21.2 percent to Inflection Point public holders, 21.6 percent to PIPE subscribers, and 7.0 percent to the sponsor, reflecting a $600 million pre-money valuation.

The filing formally triggers the proxy voting process and defines the redemption calculus for investors against a stated $10.00 per share trust assumption (filing notes the actual trust value is $10.07 and excludes interest accruing after March 31, 2026). Heavy PIPE anchoring reduces financing risk but magnifies dilution sensitivity upon any large-scale redemption event that would shrink the $533 million pro forma liquidity pool below the level required to fund the stated $(69,411) thousand 2026 cash burn. Management explicitly warns that Ranger—a design concept with 17 patented propulsion claims—is neither manufactured, operated, nor sold to date, introducing binary execution risk for the targeted 2028 product sales timeline. Executive additions like CEO Jim Bridenstine aim to leverage national security relationships to convert the cited government pipeline, while the Up-C structure dictates complex tax and voting rights allocations across Class A and B share tiers detailed in the A&R Charter exhibits.

This filing provides the first post-IPO snapshot of the trust value ($10.00 per share), the redemption deadline (March 2028), and the sponsor's non-binding PIPE commitment. The additional monthly expenses ($29,167 + $12,500) increase cash burn outside trust, which totaled $2,167,856 as of March 31, 2026. The trust includes only $24,708 in interest, far below the permitted annual withdrawal of $500,000 for working capital. Investors should monitor the 24-month clock and any future business combination announcements.

This notice fundamentally alters the liquidity and risk-return profile of the security package ahead of any acquisition phase. The explicit forfeiture of fractional warrants upon separation means holders will permanently lose a portion of warrant value during bifurcation, requiring immediate adjustment of expected payoff math and total capital exposure before the May 18, 2026 go-live date. By confirming the March 30, 2026 closing and March 26, 2026 registration effectiveness, the press release fixes the post-IPO timeline, though it deliberately omits the trust account balance, redemption threshold, or acquisition clock referenced in external trackers. The stated mandate to pursue North American or European businesses in disruptive growth sectors, alongside the disclosed executive team (Chairman Michael Blitzer, CEO Kevin Shannon, CFO Adam Saks, and Directors William Denkin, Christopher Kellen, Steven Tannenbaum, and Carolyn Trabuco), establishes governance and strategic parameters. Because decoupling creates independent pricing dynamics for equity and leveraged call options, investors monitoring redemption behavior and sponsor execution should update their position models to reflect the new separate listing environment rather than tracking bundled unit mechanics.

For investors monitoring redemption parameters and sponsor conduct, the filing locks the initial trust corpus at $253,000,000 against 25,300,000 public shares while explicitly stating that redemptions will be calculated two business days prior to consummation or, in liquidation, reduced by up to $100,000 for dissolution expenses. The registrant notes that although the Sponsor has agreed to indemnify the company if trust funds fall below the lesser of $10.00 per share or the actual trust balance, management does not believe the Sponsor possesses sufficient outside capital to satisfy those obligations because it 'believes that the Sponsor’s only assets are securities of the Company,' introducing direct liquidity risk to the trust mechanism. The filing also materializes a conditional $25,000,000 private investment in public equity commitment from Inflection Point Fund I, LP, which the registrant emphasizes is not binding until the investment committee approves it. Furthermore, the document imposes a monthly $29,167 administrative services payment to an affiliate starting March 26, 2026, details warrant exercisability constraints (starting 30 days post-combination at a $11.50 strike, with company redemption authority triggered at $18.00), and codifies founder share lock-ups and conversion ratios that directly affect post-deal ownership dilution and voting control.

This filing establishes the SPAC's trust value at $253,000,000 (~$10.00 per unit), the deadline for completing a business combination (March 30, 2028), and the foundational agreements governing warrants, trust, and sponsor restrictions. Investors should note that no business combination has been identified or announced; the SPAC is now in its search phase. The trust value and deadline are critical for redemption planning. The full exercise of the over-allotment option increases the trust and dilutes public shareholders slightly relative to the initial filing. The private placement by the sponsor and underwriter aligns incentives but introduces additional warrants that may dilute public shareholders upon exercise.

Sets the redemption and trust value baseline at $10.00 per share with a 24-month deadline ending March 2028. Investors should note the immediate dilution of ~27.7% at no redemptions, the risk of further dilution from any PIPE at potentially lower prices, and the sponsor's low cost basis. The filing also details the management team's track record with prior Inflection Point SPACs.

The filing provides the final IPO terms for a new SPAC with a $10.00 per-unit trust, a 24-month deadline from IPO closing, and a $25 million PIPE commitment from IPF. It details sponsor compensation, conflicts of interest, and redemption mechanics. This is a routine SEC filing but essential for investors evaluating the SPAC's structure and sponsor track record.

This withdrawal halts the targeted issuance timeline attached to this specific registration statement without altering the stated business combination deadline of March 30, 2028, or the published per-share trust amount of $10.07. Pulling back an acceleration request within twenty-four hours signals management’s deliberate recalibration of de-SPAC execution sequencing, which investors tracking redemption windows, extension mechanisms, or sponsor conduct should monitor as a tactical timing adjustment rather than a termination of combination efforts. The filing contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel beyond standard corporate routing and contact information for White & Case LLP attorney Joel Rubinstein at (212) 819-7642.

This is the primary registration document for the SPAC's IPO, detailing the offer of 22 million units at $10.00 per unit, with $220 million to be deposited in trust (or $253 million if the over‑allotment option is fully exercised). The filing confirms the trust value per public share is initially $10.00, the 24‑month completion deadline from the closing of the offering, the redemption mechanics, sponsor compensation, and material conflicts of interest. It also provides insight into the company's sourcing strategy through prior IPCX discussions, which may influence potential deal flow.

This document establishes the baseline terms for IPFX. Key mechanics: trust/share is $10.07 based on the offering; the deadline to complete a business combination is 24 months from the closing of this offering (or earlier if the board approves), with potential extension by amendment. The trust will hold $220,000,000 (or $253,000,000 with over-allotment). A PIPE of up to $25,000,000 from an affiliate (Inflection Point Fund I, LP) is intended but not obligated. The sponsor owns 8,433,333 founder shares (25% of post-offering shares, with up to 1,100,000 subject to forfeiture). A 15% redemption limitation applies if a shareholder vote is held. Material conflicts of interest are disclosed, including that the sponsor paid ~$0.003 per founder share, creating an incentive to complete any deal.

What changed: Amended Schedule 13G beneficial ownership report filed by LMR Partners and its affiliated entities (LMR PARTNERS Ltd, LLC, AG, (DIFC) Ltd, (Ireland) Limited) alongside principals Ben Levine and Stefan Renold. The submission lists multiple LMR Partners-affiliated vehicles and two individuals as co-filers of an amended Schedule 13G, indicating an update to their aggregate beneficial ownership disclosure for Inflection Point Acquisition VI (IPFX). The provided excerpt names the filers but contains no specific share quantities, ownership percentages, transaction dates, or acquisition methods. It includes zero references to the March 30, 2028 redemption deadline, extension negotiations, sponsor conduct, or target business progress. Why it matters: Schedule 13G amendments typically reflect material shifts in institutional positioning, which can influence shareholder voting dynamics and redemption sentiment ahead of a SPAC de-spacification. For investors calibrating their approach relative to the stated $10.07 per-share trust value, confirming whether major funds like those managed by the listed LMR Partners entities are accumulating, reducing, or merely reorganizing their IPFX stakes helps assess alignment with management’s execution trajectory. Because the excerpt withholds the actual numerical change, the direct mechanical impact on deal completion probability or trust distribution timing remains unquantifiable from this text, though the filers’ continued regulatory participation confirms active oversight of their capital allocation.

What changed: A Schedule 13G beneficial ownership report identifying Aristeia Capital, L.L.C. as a reporting holder for IPFX common stock. The provided filing excerpt names Aristeia Capital, L.L.C. as the reporting entity but contains no share counts, percentage thresholds, acquisition dates, cost basis, or transaction history. Accordingly, the document reports no quantifiable shift in ownership concentration, and makes no reference to redemption mechanics, trust distribution schedules, extension timelines, merger approval steps, or sponsor governance actions. Why it matters: Schedule 13G submissions typically flag institutional block accumulations that can subsequently affect proxy solicitation leverage, secondary market liquidity, and redemption math at the business combination vote. Because this excerpt supplies no numeric ownership data, control assertions, or intent statements from Aristeia Capital, L.L.C., it does not currently alter trust preservation pathways, deadline feasibility, or merger execution pacing. All stated holder identification and reporting obligation is attributed exclusively to Aristeia Capital, L.L.C. as set forth in the SEC Form 13G header. With zero disclosed figures or substantive operational commentary contained in the text, the filing carries no immediate material impact on deal timing, trust value handling, or shareholder redemption behavior.(flagged for human review)

What changed: Routine compliance exhibit — Amended Schedule 13G beneficial ownership report. The filing amends prior disclosures for Adage Capital Management, L.P., Robert Atchinson, and Phillip Gross regarding their beneficial ownership in IPFX. The provided excerpt contains no share quantities, percentage thresholds, or acquisition dates. Consequently, there is no observable update affecting your tracked mechanics: no indication of position adjustments that would alter redemption pressure, no modification to the stated $10.07 trust-per-share baseline, no motion to extend the 2028-03-30 deadline, and no commentary on deal progress or sponsor conduct. Why it matters: Schedule 13G/A filings serve as regulatory housekeeping for passive equity holders who previously crossed the 5% reporting line. In a SPAC operating past its merger announcement, amendments from named institutions can occasionally accompany shifts in voting strategy, liquidity positioning, or post-transaction valuation expectations. Because this excerpt omits the numerical table and transaction-purpose language, it functions as a procedural refresh rather than a tactical signal. It does not materially affect capital availability, redemption calculus, or merger execution at this time.

What changed: A Schedule 13G/A beneficial ownership report filed on 2026-08-10 (SEC accession number 0000902664-26-003368), identifying Ghisallo Capital Management LLC and Michael Germino as reporting persons. The provided filing text contains only the document designation, submission date, SEC accession identifier, and two holder names. It omits all standard 13G/A amendment components: purpose statements, aggregate share counts, percentage ownership levels, acquisition dates, purchase prices, identities of controlling parties, and any descriptions of transactions that triggered the filing threshold. Why it matters: This excerpt delivers no information relevant to IPFX’s redemption timeline, trust fund composition, extension voting mechanics, merger execution status, or sponsor conduct. Because the text includes neither operational assertions, financial metrics, partnership disclosures, nor litigation references, it cannot adjust investor expectations regarding liquidity windows, deal completion probability, or capital allocation. The absence of substantive amendment language suggests a routine regulatory update or a post-combination ownership reset, but without the complete exhibit, its procedural impact on SPAC governance or shareholder rights remains indeterminate.

What changed: A Form 425 routine compliance exhibit and deemed-filed communication under Rule 425 and Rule 14a-12, submitting a published journalistic interview and accompanying legal disclaimers for SEC review in connection with a proposed business combination. The filing introduces no amended merger terms, no new trust valuation, no extension vote, and no altered redemption mechanics. It reiterates previously disclosed capital structure: $253 million will be drawn from Inflection Point’s trust account and combined with $300 million in convertible PIPE commitments. Transaction closure targets the fourth quarter of this year, with Nasdaq listing expected under ticker QSPC. The filing confirms shareholder approval is required and explicitly flags in its risk section that 'the amount of redemption requests made by Inflection Point shareholders' constitutes a direct condition to successfully completing the combination. Why it matters: Investors tracking the redemption calendar and financing conditions should note the fourth-quarter closing target leaves substantial buffer before the 2028-03-30 liquidation deadline, but the documented risk factors confirm that aggressive redemptions could impair the trust draw needed to satisfy closing conditions. Capital is earmarked to accelerate manufacturing rather than sustain ongoing operations. All commercial, technical, and operational assertions originate from external reporting and executive statements, not historical financials or delivered deliverables: journalist Sam Royka (The Journal Record, June 23, 2026) reports Quantum Space holds contracts and pending proposals with DARPA, the Air Force Research Laboratory, the U.S. Space Force, and the Department of War, and participates in the Andromeda program; CEO Jim Bridenstine states the firm recently executed a Pentagon contract to continue developing the Ranger satellite, will construct a satellite manufacturing plant in Tulsa hiring 50 employees by the end of 2026, aims to scale production from units to dozens to hundreds, projects an operational life of up to 15 years for Ranger, and claims the platform will render U.S. military aircraft and missiles difficult to track and intercept. Management’s own risk disclosures caution that Ranger is still in development, has not been manufactured, operated, or sold to date, and faces uncertainties around launch success, explosive materials handling, supply chain reliability, government contract protests, federal budget shifts, and market demand realization. These are forward-looking representations, not validated performance metrics or guaranteed cash flows.

What changed: A Joint Filing Agreement (Exhibit A) attached to a Schedule 13G beneficial ownership report for Inflection Point Acquisition Corp. VI, dated June 16, 2026. The filing text discloses no updates to beneficial ownership percentages, voting power, or prior transaction history. It consists entirely of an administrative agreement signed by Harraden Circle Investments, LLC; Harraden Circle Investors GP, LP; Harraden Circle Investors GP, LLC; Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; Harraden Circle Concentrated, LP; and Frederick V. Fortmiller, Jr., consenting to file a single Schedule 13G on behalf of all parties under Rule 13d-1(k). Consequently, the document does not alter redemption calendars, trust accounting mechanics, extension timelines, business combination milestones, or sponsor oversight parameters. Why it matters: The filing confirms the Harraden Circle coalition retains a reportable equity position but offers no commentary on deal progression, shareholder voting strategy, or target company fundamentals. Structurally, the signature blocks show that Frederick V. Fortmiller, Jr. acts as Managing Member for the corporate general partner entities, which subsequently serve as general partners for the limited partnership vehicles. All identified relationships, entity names, and the joint filing election originate exclusively from the text and signatures provided by the listed holders. No economic targets, trust valuations, or redemption thresholds are stated or implied.

What changed: A Form 425 filing submitted under SEC Rule 425, comprising two broadcast/interview transcripts, a local newspaper article, and standard prospectus-deferral disclaimers, distributed to communicate information in connection with the proposed business combination between Inflection Point Acquisition Corp. VI and Quantum Space, LLC. The filing discloses no amendments to redemption mechanics, trust account valuations, extension provisions, or sponsor governance terms. It reaffirms the announced transaction status, confirms the merged entity will trade as QSPC on Nasdaq, and restates a fourth-quarter closing timeline contingent upon stockholder approval and customary conditions. Capital structure disclosures repeat prior public statements: the SPAC carries roughly $250 million on its balance sheet and the target company separately raised about $300 million via a PIPE. No changes to the existing deal framework or shareholder voting procedures are documented. Why it matters: As a Rule 425 communications package, this filing serves as the executive messaging vehicle preceding the definitive proxy statement/prospectus, directly impacting how investors price pre-deadline demand and post-merger liquidity. The cited $250 million SPAC balance sheet and $300 million PIPE define the immediate cash runway supporting the first Q2 delivery of the Ranger spacecraft and anchoring a QSPC enterprise valuation of $1.2 billion. Attributed claims provide commercial traction markers: CEO Jim Bridenstine asserts six Department of Defense contracts, a strategic pivot to a service model targeting predictable 15-year revenue, and specific manufacturing milestones (one satellite per quarter by the end of 2028, scaling to one per month thereafter). Bridenstine also cites macroeconomic tailwinds, stating Space Force budgets rose from $31 billion to $71 billion, and that the Andromeda program expanded from $1.8 billion to $6.2 billion IDIQ within weeks. Executive Chairman Kam Ghaffarian specifies an annual production run rate of 1,000 small satellites, each engineered with more than 8,800 pounds of storable propellant, and details a Tulsa facility launch beginning with 50 high-skill jobs. Because these figures and growth projections are sourced exclusively from televised interviews, podcast appearances, and press reporting rather than audited financials or contractual filings, they remain unverified representations. Nevertheless, they supply the baseline commercial assumptions required to evaluate dilution, execution risk, and redemption sensitivity ahead of the definitive shareholder vote.

What changed: Form 425 submission transmitting a June 11, 2026 TechCrunch article under Securities Act Rule 425 and Exchange Act Rule 14a-12, filed in connection with the proposed business combination between Inflection Point Acquisition Corp. VI and Quantum Space, LLC. No changes to redemption calendars, trust account mechanics, extension provisions, or definitive agreement terms are disclosed. The filing confirms the deal remains in the announced phase and notes that a Registration Statement—including a proxy statement/prospectus—will be filed to solicit shareholder votes, after which a record date for voting will be established. Why it matters: Beyond mechanics, the filing reprints journalistic coverage containing multiple attributed claims that may influence shareholder voting sentiment ahead of the forthcoming proxy/prospectus. According to the TechCrunch article filed by Inflection Point, the transaction values the merger at $1.2 billion. Co-founder Kam Ghaffarian tells the publication that demand for maneuverable orbital vehicles is accelerating, while CEO Jim Bridenstine asserts the company focuses exclusively on national security and participates in six government development programs, one potentially involving lunar missions. The article cites the company’s inclusion in the Andromeda contract, a $6.2 billion initiative where funded task orders commence in 2030. Author Tim Fernholz reports the financing objective includes $300 million in private investment targeting a Tulsa, Oklahoma factory capable of building one Ranger spacecraft per quarter by end of 2028, with a prototype launch scheduled for 2027. Sponsor Mike Blitzer is highlighted, alongside references to Intuitive Machines (valued at $6.4 billion in the piece) and competitor True Anomaly ($1 billion raised). Inflection Point and Quantum Space attach exhaustive forward-looking statement disclaimers cautioning that Ranger remains unmanufactured and untested, and that results hinge on regulatory approvals, shareholder consent, financing conditions, launch success, and shifting defense expenditures.

What changed: A Current Report on Form 8-K filed by Inflection Point Acquisition Corp. VI (IPFX) announcing the entry into a definitive Business Combination Agreement with Quantum Space, LLC, a space technology company. The document includes the full merger agreement, sponsor support agreement, member support agreement, forms of lock-up agreements, registration rights agreement, certificate of designation for Series A preferred stock, and a securities purchase agreement for a $240 million PIPE investment. The SPAC signed a merger agreement valuing the combined entity at approximately $1.2 billion pro forma enterprise value. Shareholders will vote and have redemption rights; the minimum cash condition requires trust proceeds after redemptions plus PIPE gross proceeds minus transaction costs to be at least $90 million. The aggregate seller consideration is $600 million divided by the per-share redemption price. Closing is expected in Q4 2026. The sponsor agreed to vote in favor, not transfer shares, and waived anti-dilution rights. A $240 million PIPE (Series A convertible preferred at $12.00) and a $60 million pre-funded Series B investment were also executed. The Outside Date for closing is one year from signing (June 8, 2027). Trust per share was $10.07 as of the filing (based on $253 million deposited for 25.3 million shares, plus interest). Why it matters: This filing establishes the definitive terms for the de-SPAC transaction, giving investors a clear framework for redemption deadlines, trust value, minimum cash condition, and deal timeline. The $90 million minimum cash condition and the link between seller consideration and the redemption price directly affect shareholder redemption decisions and the ultimate capital available to the combined company. The PIPE commitments ($300 million total) provide a significant capital infusion. The agreement also outlines governance (7-member board, SPAC appoints 1 director) and lock-up periods (6 months for sponsor and certain insiders).

What changed: Business Combination Agreement (BCA) and related ancillary documents, filed as a Form 8-K under Rule 425, announcing the definitive merger between SPAC Inflection Point Acquisition Corp. VI and Quantum Space, LLC. The SPAC entered into a definitive BCA with Quantum Space, a space technology company. The combined entity will have a pro forma enterprise value of approximately $1.2 billion. The transaction includes a $240 million Series A PIPE (19,999,994 shares of 12.0% Series A Convertible Preferred Stock at $12.00 stated value plus warrants) and a $60 million Series B pre-funded PIPE (5,882,352 Series B Preferred Units plus warrants). The trust had $253 million at IPO; the deal requires a minimum cash condition of $90 million after redemptions and expenses. The SPAC will domesticate to Delaware, then merge via an Up-C structure. The target's existing equity holders will roll over into the combined company. Sponsor has agreed to a six-month lock-up on shares and 30-day lock-up on warrants. The deal is expected to close in Q4 2026, subject to shareholder and regulatory approvals. No redemption deadline is specified beyond the shareholder vote; the trust deadline is 2028-03-30. Why it matters: This is the definitive deal announcement for IPFX, providing investors with full terms, valuation, financing, and conditions. Key metrics for redemption decisions: trust value $10.07/share, minimum cash condition $90M, and a $240M PIPE at $12.00 per preferred share (convertible at $12.00, with a VWAP reset floor of $7.00). The deal structure (Up-C, dual-class voting, convertible preferred) and the extensive representations and warranties (government contracts, IP, financials) give investors a basis to assess risk. The filing confirms sponsor support, lock-ups, and no-go shop provisions. The document is highly material for SPAC holders evaluating whether to redeem or stay invested.